Skip to main content

ADVERTISEMENT

Vikramjit Chokar, MD

Commentary
10/08/2008
Since the approval of the drug-eluting stents (DES) in April of 2003 by the U.S. Food and Drug Administration (FDA) and a year earlier in Europe, the rise of DES had been phenomenal, a feat rarely seen in contemporary medicine. With much...
Since the approval of the drug-eluting stents (DES) in April of 2003 by the U.S. Food and Drug Administration (FDA) and a year earlier in Europe, the rise of DES had been phenomenal, a feat rarely seen in contemporary medicine. With much...
Since the approval of the...
10/08/2008
Journal of Invasive Cardiology